The invention provides human kinases and phosphatases (KAP) and polnucleotides
which identify and encode KAP. The invention also provides expresson vectors, host
cells, antibodies, agonists, and antagonists. The invention also provides methods
for diagnosing, treating, or preventing disorders associated with aberrant expression
of KAP.
